Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery
| Status: | Completed |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 1/10/2019 |
| Start Date: | August 1, 2017 |
| End Date: | December 31, 2018 |
Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES): A Quality Improvement Study of Prescribing Habits and Patient Education
ORIOLES is a pre-post study designed to improve quality of opioid prescribing and use after
discharge for patients undergoing urologic surgery. The study will initially focus on a
pre-defined cohort of patients undergoing radical prostatectomy. After the predefined study
period and results are obtained, the intervention may be applied to all urologic surgeries
based on the degree of improvement demonstrated by the study.
discharge for patients undergoing urologic surgery. The study will initially focus on a
pre-defined cohort of patients undergoing radical prostatectomy. After the predefined study
period and results are obtained, the intervention may be applied to all urologic surgeries
based on the degree of improvement demonstrated by the study.
The goal of the study is to reduce the amount of opioid analgesia prescribed after urologic
surgery in the Department of Urology at Johns Hopkins. The initial quality improvement
initiative will focus on patients undergoing surgery for prostate cancer with radical
prostatectomy including patients enrolled in IRB00123618/NCT03006562. The pre-intervention
arm will consist of patients enrolled August 2017 to January 2018. The intervention arm will
consist of patient enrolled January 2018 to completion of the study.
The intervention will consist of nurses providing improved education for patients at
discharge about appropriate use of opioid medication, routes for disposal, and potential side
effects (using an education sheet). Data on prescriptions written (amount and type of
mediation) and use of opioid and other pain medication after surgery will be compared before
and after the quality improvement initiative is started. Outcomes are assessed via 30-day
phone call follow-up with data on perioperative outcomes, postoperative medication use, and
symptoms already assessed in IRB00123618/NCT03006562. Providers in the urology department
will be informed about the average and distribution of usage of post-discharge opioids by
patients to help reduce/personalize the amount of opioids prescribed at discharge to reduce
wasted medication entering circulation. The initiative may then be expanded to encompass all
urologic surgeries in the department.
surgery in the Department of Urology at Johns Hopkins. The initial quality improvement
initiative will focus on patients undergoing surgery for prostate cancer with radical
prostatectomy including patients enrolled in IRB00123618/NCT03006562. The pre-intervention
arm will consist of patients enrolled August 2017 to January 2018. The intervention arm will
consist of patient enrolled January 2018 to completion of the study.
The intervention will consist of nurses providing improved education for patients at
discharge about appropriate use of opioid medication, routes for disposal, and potential side
effects (using an education sheet). Data on prescriptions written (amount and type of
mediation) and use of opioid and other pain medication after surgery will be compared before
and after the quality improvement initiative is started. Outcomes are assessed via 30-day
phone call follow-up with data on perioperative outcomes, postoperative medication use, and
symptoms already assessed in IRB00123618/NCT03006562. Providers in the urology department
will be informed about the average and distribution of usage of post-discharge opioids by
patients to help reduce/personalize the amount of opioids prescribed at discharge to reduce
wasted medication entering circulation. The initiative may then be expanded to encompass all
urologic surgeries in the department.
Inclusion Criteria:
- All patients diagnosed with prostate cancer and enrolled in NCT03006562
Exclusion Criteria:
- Patients not undergoing radical prostatectomy (for the primary pre-post ORIOLES study)
We found this trial at
1
site
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials
